Nowadays, the diagnosis and treatment of coronary atherosclerotic heart disease (referred to as coronary heart disease) has developed rapidly, and the aspects of traditional Chinese medicine and western medicine have put forward new diagnosis and treatment ideas. This article from the obstruction of disease (CHD) of traditional Chinese medicine deficiency of vital energy and blood stasis, phlegm turbidity, and his dirty treatment to do the current masters in TCM diagnosis and treatment of coronary heart disease and new ideas in a simple, and its diagnosis and treatment related evidence of evidence-based medicine to do in a simple; from western medicine diagnosis and treatment of drug therapy and interventional therapy of coronary heart disease among recent findings do in a simple, the present situation and progress of diagnosis and treatment of coronary heart disease at home and abroad were briefly reviewed.

Bo Ning, Mingjun Zhao. Research Progress of Traditional Chinese and Western Medicine in the Treatment of Coronary Heart Disease. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 8: 86-90. https://doi.org/10.25236/IJFM.2022.040814.

[1] Mo Xingquan. New progress in the treatment of coronary heart disease in the elderly [J]. World Latest Medical Information Digest, 2019, 19(02), 29-30.

[2] Wei Jingjing, Zhu Mingjun, Yu Rui et al. Research progress of traditional Chinese medicine on the treatment of coronary heart disease [J]. Chinese Medicine Research, 2020, 33(10): 74-77.

[3] Ren Yi, Chen Keji, Zhang Minzhou et al. Correlation between coronary angiography results and TCM syndrome types in 405 patients with coronary heart disease [J]. Journal of Traditional Chinese Medicine, 2010, 51(8): 725-728.

[4] Fu Changgeng. Academician Chen Keji's academic thoughts and achievements [J]. Bulletin of Traditional Chinese Medicine, 2016, 15(4): 3-5.

[5] Liang Lizhen. The value of traditional Chinese medicine invigorating qi and activating blood in the treatment of asymptomatic myocardial ischemia patients with coronary heart disease [J]. Chinese and Foreign Medicine, 2014, (30): 159-160.

[6] Liu Haibo. Clinical observation of Buyang Huanwu Decoction in the treatment of coronary heart disease [J]. Journal of Chronic Diseases, 2018, 19(S1): 145.

[7] Li Yanmei, Wang Zhong, Weng Jin. Effect of Xuefu Zhuyu Decoction on the Function of Platelets and Hu － man Umbilical Vein Endothelial Cell [J]. CJIM, 2000, 6( 4) : 254－257.

[8] Zhong Tao. Clinical analysis of Xuefu Zhuyu Decoction in the treatment of coronary heart disease and angina pectoris [J]. Electronic Journal of Cardiovascular Diseases of Integrated Traditional Chinese and Western Medicine, 2019, 7 (35):158.

[9] Huo Lishun. Research progress in the treatment of coronary heart disease with integrated traditional Chinese and Western medicine [J]. Inner Mongolia Traditional Chinese Medicine, 2020, 09, (39): 155-156.

[10] Guo Shuanggeng, Li Na, Zhang Lin. Discussion on the relationship between phlegm stasis heat toxin and the inflammatory mechanism of atherosclerosis [J]. Journal of Traditional Chinese Medicine, 2010, 51(6): 485-487.

[11] Shen Ning. Shen Shaogong's experience in treating coronary heart disease [N]. China Journal of Traditional Chinese Medicine, 2018-04-20 (005).

[12] Li Bin, Mao Jingyuan, Jiang Feng et al. Zhang Boli in the treatment of coronary heart disease with phlegm and blood stasis syndrome combined with examples of the application of medicine [J]. Journal of Traditional Chinese Medicine, 2013, 54(11): 910-912.

[13] Yan Yafeng, Bai Haixia, Dong Bin. Research on the medication rules of Chinese medicine master Zhang Xuewen in the treatment of thoracic paralysis based on data mining [J]. Liaoning Journal of Traditional Chinese Medicine, 2018, 45(6): 1179-1182.

[14] Jin Zheng, Zhang Wenbo, Wang Chuangchang et al. The experience of Professor Deng Tietao, a master of traditional Chinese medicine, in the treatment of heart diseases with the method of "replenishing qi and raising fire" [J]. China Journal of Traditional Chinese Medicine, 2018, 33(11): 4961-4963.

[15] Wang Song, Liu Jiafen, He Xiaolian et al. Professor Deng Tietao's experience in treating coronary heart disease with the method of nourishing qi, removing phlegm and activating blood [J]. Chinese Journal of Traditional Chinese Medicine, 2019, 37(3): 699-702.

[16] Wu Di, Zhang Qingjun. Status and progress of diagnosis and treatment of coronary heart disease in China [J]. Department of Cardiovascular Medicine, Emergency General Hospital of China Research Hospital, 2020, 32(7): 1.

[17] Fox KA, Mehta SR, Peters R et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome:the clopidogrel in unstable Angina to prevent recurrent is chemic events (CURE) trial [J]. Circulation. 2004. 110(10): 1202-1208

[18] Deng Shuqiang. Research progress on the correlation between paraoxonase-1Q192R gene polymorphism and the efficacy of clopidogrel in the treatment of coronary heart disease. Journal of Mudanjiang Medical College. 2020, 40(5):106-109.

[19] Dai Yuxiang, Ge Junbo. Annual inventory of cardiovascular interventional therapy in 2018 [J]. China Medical Information Herald. 2019.34(3):12-13.

[20] Chinese Adult Dyslipidemia Prevention and Control Guidelines Revision Joint Committee. Chinese Adult Dyslipidemia Prevention and Control Guidelines (2016 Revised Edition) [J]. Chinese Journal of General Practitioners. 2017.16(1): 15--35. 

[21] Knuuti J, Wijns W, Saraste A et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur heart J. 2019.

[22] Liu Yuwen. Feasibility and safety of coronary intervention via distal radial artery. Journal of Microcirculation, 2020, 30(2): 39-43.

[23] Liu Jing, Zhang Yan. Research progress of traditional Chinese medicine in the treatment of coronary heart disease and angina pectoris [J/OL]. Journal of Practical Chinese Medicine 2021, 01: 1-6.